{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:46:28Z","timestamp":1790667988215,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["19255"],"award-info":[{"award-number":["19255"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2011-02348722"],"award-info":[{"award-number":["GR-2011-02348722"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/carcin\/bgx077","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T15:09:21Z","timestamp":1500736161000},"page":"1011-1020","source":"Crossref","is-referenced-by-count":20,"title":["Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra high-risk patients"],"prefix":"10.1093","volume":"38","author":[{"given":"Roberta","family":"Russo","sequence":"first","affiliation":[{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli Federico II, Napoli, Italy,"},{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Cimmino","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli Federico II, Napoli, Italy,"},{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pezone","sequence":"additional","affiliation":[{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"},{"name":"Department of Medicine, University of Verona,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Manna","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli Federico II, Napoli, Italy,"},{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Avitabile","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli Federico II, Napoli, Italy,"},{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Langella","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli Federico II, Napoli, Italy,"},{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Koster","sequence":"additional","affiliation":[{"name":"Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorina","family":"Casale","sequence":"additional","affiliation":[{"name":"Servizio di Oncologia Pediatrica, Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica\u2014Seconda Universit\u00e0 degli Studi di Napoli, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Raia","sequence":"additional","affiliation":[{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampietro","family":"Viola","sequence":"additional","affiliation":[{"name":"Dipartimento di Salute della Donna e del Bambino, Universit\u00e0 degli Studi di Padova, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University of Cologne Children\u2019s Hospital, Cologne, Germany,"},{"name":"Center for Molecular Medicine Cologne (CMMC), Cologne, Germany and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Iolascon","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli Federico II, Napoli, Italy,"},{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Capasso","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universit\u00e0 degli Studi di Napoli Federico II, Napoli, Italy,"},{"name":"CEINGE Biotecnologie Avanzate, Napoli, Italy,"},{"name":"IRCCS SDN, Istituto di Ricerca Diagnostica e Nucleare, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"key\n\t\t\t\t20180328194052_CIT0001","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20180328194052_CIT0002","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20180328194052_CIT0003","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1158\/1078-0432.CCR-13-0680","article-title":"New strategies in neuroblastoma: therapeutic targeting of MYCN and ALK","volume":"19","author":"Barone","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.peptides.2016.01.014","article-title":"VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells","volume":"78","author":"de Boisvilliers","year":"2016","journal-title":"Peptides"},{"key":"key\n\t\t\t\t20180328194052_CIT0005","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/pbc.24433","article-title":"Children\u2019s Oncology Group\u2019s 2013 blueprint for research: neuroblastoma","volume":"60","author":"Park","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"key\n\t\t\t\t20180328194052_CIT0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2867-11-9","article-title":"A 6-gene signature identifies four molecular subgroups of neuroblastoma","volume":"11","author":"Abel","year":"2011","journal-title":"Cancer Cell Int"},{"key":"key\n\t\t\t\t20180328194052_CIT0007","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1158\/1078-0432.CCR-09-2607","article-title":"Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature","volume":"16","author":"De Preter","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0008","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1158\/1078-0432.CCR-11-2483","article-title":"A three-gene expression signature model for risk stratification of patients with neuroblastoma","volume":"18","author":"Garcia","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0009","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(09)70154-8","article-title":"Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN\/COG\/GPOH study","volume":"10","author":"Vermeulen","year":"2009","journal-title":"Lancet. Oncol"},{"key":"key\n\t\t\t\t20180328194052_CIT0010","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2011.40.9169","article-title":"Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma","volume":"30","author":"Asgharzadeh","year":"2012","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20180328194052_CIT0011","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2009.27.3367","article-title":"Prognostic impact of gene expression-based classification for neuroblastoma","volume":"28","author":"Oberthuer","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20180328194052_CIT0012","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12967-016-0896-7","article-title":"An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma","volume":"14","author":"Formicola","year":"2016","journal-title":"J. Transl. Med"},{"key":"key\n\t\t\t\t20180328194052_CIT0013","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1200\/JCO.2013.53.3604","article-title":"Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1\/SIOPEN study","volume":"32","author":"Viprey","year":"2014","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20180328194052_CIT0014","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbrc.2012.04.034","article-title":"Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers","volume":"421","author":"Cho","year":"2012","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20180328194052_CIT0015","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/carcin\/bgs018","article-title":"Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients","volume":"33","author":"Hildebrandt","year":"2012","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20180328194052_CIT0016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-8794-7-4","article-title":"Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy","volume":"7","author":"Kuijjer","year":"2014","journal-title":"BMC Med. Genomics"},{"key":"key\n\t\t\t\t20180328194052_CIT0017","doi-asserted-by":"crossref","first-page":"W63","DOI":"10.1093\/nar\/gkt338","article-title":"INMEX\u2013a web-based tool for integrative meta-analysis of expression data","volume":"41","author":"Xia","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0018","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328194052_CIT0019","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180328194052_CIT0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev"},{"key":"key\n\t\t\t\t20180328194052_CIT0021","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.18632\/oncotarget.2027","article-title":"A novel copper(I) complex induces ER-stress-mediated apoptosis and sensitizes B-acute lymphoblastic leukemia cells to chemotherapeutic agents","volume":"5","author":"Bortolozzi","year":"2014","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180328194052_CIT0022","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0023","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature14336","article-title":"Therapy-induced tumour secretomes promote resistance and tumour progression","volume":"520","author":"Obenauf","year":"2015","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328194052_CIT0024","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1158\/1078-0432.CCR-10-0284","article-title":"Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma","volume":"16","author":"Smida","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1158\/1078-0432.CCR-10-1129","article-title":"Polo-like kinase 1 is a therapeutic target in high-risk neuroblastoma","volume":"17","author":"Ackermann","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0026","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1753465815617871","article-title":"Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches","volume":"10","author":"Shea","year":"2016","journal-title":"Ther. Adv. Respir. Dis"},{"key":"key\n\t\t\t\t20180328194052_CIT0027","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1158\/1078-0432.CCR-08-2699","article-title":"Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds","volume":"15","author":"De Preter","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0028","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t20180328194052_CIT0029","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2174\/138161213804143617","article-title":"Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical development","volume":"19","author":"Soga","year":"2013","journal-title":"Curr. Pharm. Des"},{"key":"key\n\t\t\t\t20180328194052_CIT0030","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-0032-1323692","article-title":"Phase I\/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma or leukemia","volume":"224","author":"Witt","year":"2012","journal-title":"Klin. Padiatr"},{"key":"key\n\t\t\t\t20180328194052_CIT0031","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-007-9505-1","article-title":"Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA)","volume":"87","author":"Spiller","year":"2008","journal-title":"J. Neurooncol"},{"key":"key\n\t\t\t\t20180328194052_CIT0032","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.2009.25.9119","article-title":"Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children\u2019s Oncology Group phase I consortium report","volume":"28","author":"Fouladi","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20180328194052_CIT0033","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1158\/1541-7786.MCR-09-0187","article-title":"UNC45A confers resistance to histone deacetylase inhibitors and retinoic acid","volume":"7","author":"Epping","year":"2009","journal-title":"Mol. Cancer Res"},{"key":"key\n\t\t\t\t20180328194052_CIT0034","doi-asserted-by":"crossref","first-page":"17777","DOI":"10.1073\/pnas.0702518104","article-title":"A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors","volume":"104","author":"Epping","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"key\n\t\t\t\t20180328194052_CIT0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13402-015-0233-9","article-title":"MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells","volume":"38","author":"Cort\u00e9s","year":"2015","journal-title":"Cell. Oncol. (Dordr)"},{"key":"key\n\t\t\t\t20180328194052_CIT0036","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.clml.2011.03.027","article-title":"HSP90 inhibitors as therapy for multiple myeloma","volume":"11","author":"Usmani","year":"2011","journal-title":"Clin. Lymphoma. Myeloma Leuk"},{"key":"key\n\t\t\t\t20180328194052_CIT0037","doi-asserted-by":"crossref","first-page":"e63566","DOI":"10.1371\/journal.pone.0063566","article-title":"Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma","volume":"8","author":"Murata","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328194052_CIT0038","doi-asserted-by":"crossref","first-page":"987612","DOI":"10.1155\/2013\/987612","article-title":"HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells","volume":"2013","author":"Wu","year":"2013","journal-title":"Evid. Based. Complement. Alternat. Med"},{"key":"key\n\t\t\t\t20180328194052_CIT0039","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11010-011-0997-9","article-title":"Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins","volume":"359","author":"Kim","year":"2012","journal-title":"Mol. Cell. Biochem"},{"key":"key\n\t\t\t\t20180328194052_CIT0040","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"key\n\t\t\t\t20180328194052_CIT0041","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/mol.62.5.975","article-title":"Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha\/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol","volume":"62","author":"Hur","year":"2002","journal-title":"Mol. Pharmacol"},{"key":"key\n\t\t\t\t20180328194052_CIT0042","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1038\/srep11158","article-title":"Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells","volume":"5","author":"Cimmino","year":"2015","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180328194052_CIT0043","doi-asserted-by":"crossref","first-page":"e93960","DOI":"10.1371\/journal.pone.0093960","article-title":"Synergistic and antagonistic drug combinations depend on network topology","volume":"9","author":"Yin","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328194052_CIT0044","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","article-title":"Requirement for p53 and p21 to sustain G2 arrest after DNA damage","volume":"282","author":"Bunz","year":"1998","journal-title":"Science"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/38\/10\/1011\/20991001\/bgx077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T03:57:39Z","timestamp":1522295859000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/38\/10\/1011\/4096713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,8,29]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgx077","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,8,29]]}}}